We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the different types of testicular cancer, including germ cell tumors (seminomas and nonseminomas), stromal tumors, and secondary cancers. Understand symptoms, diagnosis, and treatment.

Understanding Testicular Cancer Types: A Comprehensive Guide Testicular cancer is a type of cancer that develops in the testicles, which are part of the male reproductive system. While it is one of the less common cancers, understanding its different types is crucial for accurate diagnosis, effective treatment, and improved outcomes. This guide aims to provide a clear and practical overview of the various forms of testicular cancer, tailored for readers in India. What is Testicular Cancer? Testicular cancer occurs when cells in the testicles begin to grow out of control and form a tumor. The testicles are two oval-shaped glands located in the scrotum, responsible for producing sperm and male hormones like testosterone. Most testicular cancers are germ cell tumors, which originate from the cells that produce sperm. Germ Cell Tumors: The Most Common Type Germ cell tumors (GCTs) account for about 95% of all testicular cancers. These tumors arise from germ cells, the cells responsible for sperm production. GCTs are further divided into two main categories: seminomas and nonseminomas. These categories are important because they can influence the treatment approach and prognosis. Seminomas Seminomas are a type of germ cell tumor that typically grows slowly and is highly treatable, especially when detected early. They are most common in men between the ages of 25 and 45, although they can occur at any age. There are two subtypes of seminomas: Classical Seminomas: These are the most common type, accounting for over 95% of all seminomas. They tend to occur in younger men and are highly responsive to radiation therapy and chemotherapy. Spermatocytic Seminomas: These are much rarer and usually affect older men, typically over 50. They tend to grow more slowly than classical seminomas and are less likely to spread. Treatment for seminomas often involves surgery to remove the affected testicle (radical orchiectomy), followed by chemotherapy or radiation therapy if necessary. The 5-year survival rate for seminomas, when treated before metastasis, is very high, often around 99%. Nonseminomas Nonseminomas are another type of germ cell tumor. They tend to grow and spread more quickly than seminomas, making early diagnosis and prompt treatment essential. Nonseminomas can occur at any age but are most common in men between the ages of 15 and 35. Unlike seminomas, nonseminomas are less sensitive to radiation therapy but respond well to chemotherapy. There are four main subtypes of nonseminomas, though it's common for a nonseminoma tumor to be a mix of these subtypes: Embryonal Carcinoma: This is a fast-growing tumor that can spread to other parts of the body. It is found in about 40% of testicular tumors. Yolk Sac Carcinoma (Endodermal Sinus Tumor): This is the most common type of testicular cancer found in children and infants. It is named because it resembles the yolk sac of an embryo. Choriocarcinoma: This is a rare but very aggressive type of testicular cancer that tends to spread rapidly, often to the lungs, brain, and bones. Teratoma: Teratomas are tumors that contain different types of tissue, such as hair, teeth, or bone. They can be mature (benign) or immature (cancerous). Treatment for nonseminomas typically involves surgery, chemotherapy, and sometimes radiation therapy. The specific treatment plan depends on the subtype and stage of the cancer. Carcinoma in Situ (CIS) Carcinoma in situ, also known as intratubular germ cell neoplasia, is a non-invasive precancerous condition. In CIS, abnormal germ cells are present in the testicles but have not yet formed a tumor or spread. It is often discovered incidentally during fertility tests or when investigating other testicular issues. While CIS does not always progress to invasive cancer, there is a significant chance (around 50% according to some studies) that it can develop into a malignant germ cell tumor. Doctors often recommend close monitoring with regular physical exams, ultrasounds, and blood tests for individuals with CIS. Sex Cord Stromal Tumors (SCSTs) Stromal tumors originate from the supportive tissues of the testicles, known as the stroma. These tissues produce hormones like testosterone. SCSTs are much less common than germ cell tumors, accounting for only about 5% of all testicular tumors. However, they are the second most common type of testicular tumor in children. The two main types of SCSTs are: Leydig Cell Tumors: These tumors arise from Leydig cells, which produce testosterone. Sertoli Cell Tumors: These tumors arise from Sertoli cells, which play a role in sperm development. SCSTs can occur at any age and may sometimes produce excess hormones, leading to symptoms like early puberty in boys or breast enlargement in men. Treatment usually involves surgery. Secondary Testicular Cancers Secondary testicular cancers are not true testicular cancers because they originate in another part of the body and spread (metastasize) to the testicles. The most common type of cancer that spreads to the testicles is lymphoma, a cancer of the lymphatic system. Other cancers that can spread to the testicles include kidney cancer and cancers of the abdominal organs. The symptoms of secondary testicular cancer can be similar to primary testicular cancer, but the treatment approach will focus on the original cancer type. Symptoms of Testicular Cancer It is important to be aware of the potential symptoms of testicular cancer. These can include: A lump or swelling in either testicle, which may be painless. A feeling of heaviness in the scrotum. A dull ache in the abdomen or groin. Sudden collection of fluid in the scrotum. Pain or discomfort in a testicle
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026